1003-3734
2009 Issue 19
..............page:1816
Progress in clinical application of analgesic treatment with oxycodone-acetaminophen
zhou hong-jun; zhang ji-feng; wang xiao-yu(department of traditional chinese medicine; medical college of cangzhou; cangzhou 061001; china)
zhou hong-jun; zhang ji-feng; wang xiao-yu(department of traditional chinese medicine; medical college of cangzhou; cangzhou 061001; china)
..............page:1843-1845
A new synthetic method of nedaplatin-a platinum-based antitumor drug
cong yan-wei1; wang qing-kun1; 2; zhu ze-bing1; liu zhu-dong1; pu shao-ping1; 3(1 kunming guiyan pharmaceutical co.; ltd; kunming 650106; china; 2 kunming institute of precious metals; kunming 650106; china; 3 engineering institute of material and metallurgy; kunming university of science and technology; kunming 650093; china)
cong yan-wei1; wang qing-kun1; 2; zhu ze-bing1; liu zhu-dong1; pu shao-ping1; 3(1 kunming guiyan pharmaceutical co.; ltd; kunming 650106; china; 2 kunming institute of precious metals; kunming 650106; china; 3 engineering institute of material and metallurgy; kunming university of science and technology; kunming 650093; china)
..............page:1886-1887
Preventive effect of polydatin on hypoxic pulmonary hypertension in rats and the mechanism
miao qing; wang si-wang; wang jian-bo; miao shan; sun ji-yuan; xie yan-hua(institute of materia medica; school of pharmacy; fourth military medical university; xi an 710032; china)
miao qing; wang si-wang; wang jian-bo; miao shan; sun ji-yuan; xie yan-hua(institute of materia medica; school of pharmacy; fourth military medical university; xi an 710032; china)
..............page:1872-1876
Analysis of the protection to marketing approval data under the TRIPS Agreement
bai ting1; chen jing1; 2; shi lu-wen1; 2(1 school of pharmaceutical sciences; 2 international research center for medicinal administration; peking university; beijing 100191; china)
bai ting1; chen jing1; 2; shi lu-wen1; 2(1 school of pharmaceutical sciences; 2 international research center for medicinal administration; peking university; beijing 100191; china)
..............page:1823-1825,1830
Key issues involved in the development of drug targets
zhang yin; wang song-jun; diao tian-xi; lou tie-zhu(institute of health service and medical information; academy of military medical sciences; beijing 100850; china)
zhang yin; wang song-jun; diao tian-xi; lou tie-zhu(institute of health service and medical information; academy of military medical sciences; beijing 100850; china)
..............page:1834-1837
Pharmacology and clinical evaluation of alvimopan
yue xiang-yang1; 2; shi ai-xin2; fu de-xing2; wang wei-hong1; hu xin2(1 institute of pharmaceutical analysis; college of pharmacy; shandong university; jinan 250012; china; 2 department of pharmacy; beijing hospital; the ministry of health; beijing 100730; china)
yue xiang-yang1; 2; shi ai-xin2; fu de-xing2; wang wei-hong1; hu xin2(1 institute of pharmaceutical analysis; college of pharmacy; shandong university; jinan 250012; china; 2 department of pharmacy; beijing hospital; the ministry of health; beijing 100730; china)
..............page:1819-1822
Investigation of property and preliminary safety of 2-methoxyestradiol intravenous emulsions
zhang li-na; hu hai-ying; ma wei-feng; zhang zheng-quan; zhang zhen-zhong(school of pharmaceutical science; zhengzhou university; zhengzhou 450001; china)
zhang li-na; hu hai-ying; ma wei-feng; zhang zheng-quan; zhang zhen-zhong(school of pharmaceutical science; zhengzhou university; zhengzhou 450001; china)
..............page:1877-1881
Preparation of probucol loaded chitosan nanoparticles and in vitro release study
gao li1; wan a-jun2(1 school of environment and resource; ningxia university; yinchuan 750021; china; 2 school of chemistry and chemical technology; shanghai 200240; china)
gao li1; wan a-jun2(1 school of environment and resource; ningxia university; yinchuan 750021; china; 2 school of chemistry and chemical technology; shanghai 200240; china)
..............page:1892-1896
Consideration of key factors during film coating scale up process
cai zhi-gang1; liu yong-xiang2; ren ping-yuan3(1 shanghai colorcon coating technology co.; ltd.; shanghai 201108; china; 2 jiangxi herbi-sky yiyang pharmaceutical co.; ltd.; yiyang 334400; china; 3 wuhan jianmin group suizhou pharmaceutical co.; ltd.; suizhou 441300; china)
cai zhi-gang1; liu yong-xiang2; ren ping-yuan3(1 shanghai colorcon coating technology co.; ltd.; shanghai 201108; china; 2 jiangxi herbi-sky yiyang pharmaceutical co.; ltd.; yiyang 334400; china; 3 wuhan jianmin group suizhou pharmaceutical co.; ltd.; suizhou 441300; china)
..............page:1902-1904,1917
Determination of clioquinol in clioquinol cream by HPLC
jiang yan-hong1; li xiang-jun2; geng jia3; zhang yi4(1 shijiazhuang huaxin pharmaceutical factory; shijiazhuang 050091; china; 2 hebei yiling academy of medicine; shijiazhuang 050035; china; 3 hebei university of science and technology; shijiazhuang 050018; china; 4 institute for drug control of hebei province; shijiazhuang 050011; china)
jiang yan-hong1; li xiang-jun2; geng jia3; zhang yi4(1 shijiazhuang huaxin pharmaceutical factory; shijiazhuang 050091; china; 2 hebei yiling academy of medicine; shijiazhuang 050035; china; 3 hebei university of science and technology; shijiazhuang 050018; china; 4 institute for drug control of hebei province; shijiazhuang 050011; china)
..............page:1888-1891
Study on the quality standard of Zhuifengtougu capsule
wang yan1; peng hong-ying2; zhou li-ling3; lu song-gui2; lin wei-xiong2(1 guangdong pharmaceutical university; guangzhou 510006; china; 2 guangzhou jing xiu tang pharmaceutical co.; ltd.; guangzhou 510130; china; 3 guangzhou university of traditional chinese medicine; guangzhou 510405; china)
wang yan1; peng hong-ying2; zhou li-ling3; lu song-gui2; lin wei-xiong2(1 guangdong pharmaceutical university; guangzhou 510006; china; 2 guangzhou jing xiu tang pharmaceutical co.; ltd.; guangzhou 510130; china; 3 guangzhou university of traditional chinese medicine; guangzhou 510405; china)
..............page:1910-1913
..............page:1812
dian pa chun zao ying ji yin qi de bu liang fan ying 3 li bao gao
su jia gui ; tian mei
su jia gui ; tian mei
..............page:1919-1920
..............page:1815
Application of quality risk management (QRM) in drug GMP site inspection
xiao jiang-yi1; ping qi-neng2(1 center for drug certification; state food and drug administration; beijing 100061; china; 2 china pharmaceutical university; nanjing 210009; china)
xiao jiang-yi1; ping qi-neng2(1 center for drug certification; state food and drug administration; beijing 100061; china; 2 china pharmaceutical university; nanjing 210009; china)
..............page:1826-1830
Key factors of shelf life establishment for drug products
chen hai-feng(center of drug evaluation; state food and drug administration; beijing 100038; china)
chen hai-feng(center of drug evaluation; state food and drug administration; beijing 100038; china)
..............page:1831-1833,1885
Advances in synthesis of new antibiotics by modifying glycosyl chains
zhou shu-fang; qiu juan-ping(college of biological and environmental engineering; zhejiang university of technology; hangzhou 310014; china)
zhou shu-fang; qiu juan-ping(college of biological and environmental engineering; zhejiang university of technology; hangzhou 310014; china)
..............page:1838-1842,1845
Ganciclovir-induced serious leukocytopenia: 1 case reports
pang xiao-yun; shen jin-fang(department of pharmacy; renji hospital; medical college of shanghai jiaotong university; shanghai 200127; china)
pang xiao-yun; shen jin-fang(department of pharmacy; renji hospital; medical college of shanghai jiaotong university; shanghai 200127; china)
..............page:1918
Synthesis and characterization of isoliquiritigenin derivatives
li hong-zhi1; anwar mamat2; mourboul ablise1; ubul niyaz1; rekiyem turdi1(1 college of pharmacy; xinjiang medical university; 2 affiliated hospital of oncology; xinjiang medicaluniversity; urumqi 830054; china)
li hong-zhi1; anwar mamat2; mourboul ablise1; ubul niyaz1; rekiyem turdi1(1 college of pharmacy; xinjiang medical university; 2 affiliated hospital of oncology; xinjiang medicaluniversity; urumqi 830054; china)
..............page:1882-1885
Absorption characteristics of 4 linear furocoumarins across human intestinal epithelial in a model of Caco-2 cell monolayer
long jie; li su-ning; yang xiu-wei(state key laboratory of natural and biomimetic drugs & department of natural medicines; school of pharmaceuticalsciences; peking university; beijing 100191; china)
long jie; li su-ning; yang xiu-wei(state key laboratory of natural and biomimetic drugs & department of natural medicines; school of pharmaceuticalsciences; peking university; beijing 100191; china)
..............page:1865-1871
Pharmaceutical care for a peritoneal dialysis patient with peritoneal dialysis related peritonitis
han jing1; 2; zhou ying1; cui yi-min1(1 department of pharmacy; peking university first hospital; beijing 100034; china; 2 department of pharmaceutical administration and clinical pharmacy; school of pharmaceutical sciences; peking university; beijing 100083; china)
han jing1; 2; zhou ying1; cui yi-min1(1 department of pharmacy; peking university first hospital; beijing 100034; china; 2 department of pharmaceutical administration and clinical pharmacy; school of pharmaceutical sciences; peking university; beijing 100083; china)
..............page:1914-1917
Preparation of self-microemulsifying drug delivery system (SMEDDS) of vinpocetine and in vitro evaluation
cui shu-xia; nie shu-fang; zhang shi-zhong; xu xin; zhou xiao-tang; pan wei-san(school of pharmacy; shenyang pharmaceutical university; shenyang 110016; china)
cui shu-xia; nie shu-fang; zhang shi-zhong; xu xin; zhou xiao-tang; pan wei-san(school of pharmacy; shenyang pharmaceutical university; shenyang 110016; china)
..............page:1897-1901
Preventive effect of Silibinin capsules on liver damage induced by antitubercular drugs
sun li-ru; xia jing; akemujiang(department of infectious diseases; the 23th hospital of pla; urumqi 830001; china)
sun li-ru; xia jing; akemujiang(department of infectious diseases; the 23th hospital of pla; urumqi 830001; china)
..............page:1858-1859,1920
[BT(2+2]Early enteral application of probiotics improved the changes of inflammatory mediators and its relationship with the prognosis in the patients with severe acute pancreatitis
cui li-hong; wang shao-xin; wang xiao-hui; pu jiang; liu chao-qun; fu shan-feng; yu lan(department of gastroenterology; navy general hospital of pla; beijing 100048; china)
cui li-hong; wang shao-xin; wang xiao-hui; pu jiang; liu chao-qun; fu shan-feng; yu lan(department of gastroenterology; navy general hospital of pla; beijing 100048; china)
..............page:1854-1857
..............page:1837
Analgesic effect of ropivacaine combined with fentanyl after cesarean section and the effect on serum prolactin
yue hong-li1; dong gang2; feng zhong1; li yan-ping1; li shu-ren1(1 department of anesthesiology; beijing friendship hospital; affiliated of capital university of medicalsciences; beijing 100050; china; 2 department of anesthesiology; beijing haidian maternal and childhealth hospital; beijing 100080; china)
yue hong-li1; dong gang2; feng zhong1; li yan-ping1; li shu-ren1(1 department of anesthesiology; beijing friendship hospital; affiliated of capital university of medicalsciences; beijing 100050; china; 2 department of anesthesiology; beijing haidian maternal and childhealth hospital; beijing 100080; china)
..............page:1850-1853,1864
Efficacy of etanercept in patients with ankylosing spondylitis: a double-blind,randomized,placebo controlled trial
zhang jie; zhang ya-mei; zhang jiang-lin; deng xiao-hu; huang feng(department of rheumatology; pla general hospital; beijing 100853; china)
zhang jie; zhang ya-mei; zhang jiang-lin; deng xiao-hu; huang feng(department of rheumatology; pla general hospital; beijing 100853; china)
..............page:1846-1849,1881
Primary studies on preparation technology and quality control standard of Zhenyuan soft capsules
xie xiao-qing1; chen dong-mei1; yan dong1; gan zi-zhen2(1 e.living pharmaceutical company ltd.of shenyang; shenyang 110179; china; 2 graduate university of chinese academy of sciences; beijing 100049; china)
xie xiao-qing1; chen dong-mei1; yan dong1; gan zi-zhen2(1 e.living pharmaceutical company ltd.of shenyang; shenyang 110179; china; 2 graduate university of chinese academy of sciences; beijing 100049; china)
..............page:1905-1909
Long-term toxicity of intramuscularly injected paratyphoid A polysaccharide protein binding vaccine in rats
zhai jing; zhu li-juan; li zhi-cheng; li wen-guang; wu yong-jie; gao ming-tang(department of pharmacology; school of basic medical sciences; lanzhou university; gansu province keylaboratory of preclinical study for new drugs; lanzhou 730000; china)
zhai jing; zhu li-juan; li zhi-cheng; li wen-guang; wu yong-jie; gao ming-tang(department of pharmacology; school of basic medical sciences; lanzhou university; gansu province keylaboratory of preclinical study for new drugs; lanzhou 730000; china)
..............page:1860-1864
..............page:1817-1818